IPO Outlook For The Week: Biotechs And Blank Checks
For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. IPO dates below are expected but not confirmed.
Alector, Inc. (ALEC) will issue 9.25 million shares between $18 and $20 Thursday on the Nasdaq. The San Francisco biotech develops therapies for Alzheimer’s Disease and Frontotemporal Dementia.
Gossamer Bio, Inc. (GOSS) will issue 14.375 million shares at $16 Friday on the Nasdaq. Based in San Diego, the pharmaceutical company develops treatments in the fields of immunology, inflammation, immuno-oncology and fibrosis.
Harpoon Therapeutics, Inc. (HARP) will issue 5.4 million shares between $13 and $15 Friday on the Nasdaq. The firm’s immuno-oncology pipeline uses T-cells to target prostate, ovarian and small-cell lung cancer, as well as multiple myeloma.
Monocle Acquisition (MNCLU) will issue 15 million shares at $10 Thursday on the Nasdaq. The blank-check company will target financially businesses in the aerospace and defense, industrial, technology and telecom industries.
Related Links:
What Is Reg A+?
What Is A Lock-Up Expiration Date And Why Is It Important?
See more from Benzinga
Analysts Hesitant To Pick Up Nintendo As Hardware Sales Slow
US Unemployment Rises To 4%, January Payroll Blows Away Estimates
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
